Mirae Asset Global ETFs Holdings’s Larimar Therapeutics LRMR Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio LRMR Stock Details LRMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$93.5K	Buy	30,652 +7,561	+33%	+$30K	﹤0.01%	2856
2026 Q1	$104K	Buy	23,091 +544	+2%	+$2.17K	﹤0.01%	2650
2025 Q4	$85.9K	Buy	22,547 +704	+3%	+$2.74K	﹤0.01%	2737
2025 Q3	$70.6K	Sell	21,843 -2,274	-9%	-$8.53K	﹤0.01%	2828
2025 Q2	$69.7K	Sell	24,117 -1,092	-4%	-$2.53K	﹤0.01%	2775
2025 Q1	$54.2K	Buy	25,209 +1,092	+5%	+$3.45K	﹤0.01%	2835
2024 Q4	$93.3K	Buy	24,117 +1,064	+5%	+$7.02K	﹤0.01%	2732
2024 Q3	$151K	Buy	23,053 +10,037	+77%	+$80.7K	﹤0.01%	2511
2024 Q2	$94.4K	Buy	+13,016	New	+$99.7K	﹤0.01%	2587

Other funds holding LRMR

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCM

Defilade Capital Management Emeryville, California $747M AUM

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's LRMR Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Larimar Therapeutics (LRMR) stake by 33% in Q2 2026, buying an estimated $30K and bringing the position to 30,652 shares worth $93.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2856.

Mirae Asset Global ETFs Holdings first reported a position in LRMR in Q2 2024 and has held it in 9 quarters since. The position peaked at $151K in Q3 2024. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

Mirae Asset Global ETFs Holdings held 30,652 shares of Larimar Therapeutics worth $93.5K as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 7,561 Larimar Therapeutics shares in Q2 2026, an estimated $30K.
Larimar Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2856 holding.
Mirae Asset Global ETFs Holdings first reported a position in Larimar Therapeutics in Q2 2024 and has held it in 9 quarters since.
Mirae Asset Global ETFs Holdings's Larimar Therapeutics position peaked at $151K in Q3 2024.
163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.